2023 - Pros and Cons in General Internal Medicine and Geriatrics
Keywords:
Pros and Cons, General Internal Medicine, GeriatricsAbstract
.
References
W.H.O. Europe: By 2024, the 65-and-over age group will outnumber the youth group: new WHO report on healthy ageing,11 October 2023 News release.
Szychowska A, Drygas W. Physical activity as a determinant of successful aging: a narrative review article. Aging Clin Exp Res. 2022;34(6):1209-14. doi: 10.1007/s40520-021-02037-0.
Bruyere O, Kaux JF. How much sport is too much? A focus on musculoskeletal health of the adult. Aging Clin Exp Res.2023;35: 1401–3.doi: 10.1007/s40520-023-02448-1.
-Liu M, Ning Y, Teixayavong S, et al. A translational perspective towards clinical AI fairness. NPJ Digit Med. 2023; 6:172. doi:10.1038/s41746-023-00918-4.
Sivula T, Poso A, Pöhner I, et. al. Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries. J Chem Inf Model. 2023; 63 (18):5773-83.doi:10.1021/acs.jcim.3c01239.
Ferreira G E, Abdel-Shaheed C, Underwood M, et al. Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews. BMJ. 2023;380: e072415. doi: 10.1136/bmj-2022-072415.
Rescape. The Evidence for Virtual Reality in the Clinic. 2021. 10 July 2023.
Reddy VY, Lehmann JW, Gerstenfeld EP, et al. A randomized controlled trial of pulsed field ablation versus standard-of-care ablation for paroxysmal atrial fibrillation: The ADVENT trial rationale and design. Heart Rhythm O2. 2023; 4:317-28. doi: 10.1016/j.hroo.2023.03.001.
Feldman WB, Avorn J, Kesselheim AS, Gagne JJ. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers. JAMA Intern Med. 2023;183(7):685-95. doi: 10.1001/jamainternmed.2023.1245.
Pirracchio R, Annane D, Waschka AK, et al. Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock. NEJM Evid. 2023;2(6).doi: 10.1056/EVIDoa2300034.
Rao SSC, Quigley EMM, Chey WD, Sharma A, Lembo AJ. Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation. Gastroenterology. 2023;164(7):1202-10. doi: 10.1053/j.gastro.2023.02.013.
Campobasso D, Morselli S, Greco F, et al. Efficacy and safety profile of Greenlight laser photo selective vaporization of the prostate in ≥ 75 years old patients: results from the Italian Greenlight Laser Study Group. Aging Clin Exp Res.2023;35:877–85.doi.org/10.1007/s40520-023-02351-9.
Hussein AA, Iqbal U, Jing Z, Ramahi Y, et al. Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer. J Natl Compr Canc Netw. 2023 ;21(4):359-65.doi: 10.6004/jnccn.2022.7090.
Varley PR., Buchanan B, Bilderback A, et al. Association of Routine Preoperative Frailty Assessment With 1-Year Postoperative Mortality JAMA Surg. 2023;158:475-83. doi:10.1001/jamasurg. 2022.8341.
Collins EC,Renshaw S, Adib M, et al. Frailty in emergency general surgery: Low-risk procedures pose similar risk as high-risk procedures for frail patients. Surgery. 2023;173(2):485-91.doi:10.1016/j. surg.2022.10.002.
Johansen ND, Modin D, Nealon J, et al. A Pragmatic Randomized Feasibility Trial of Influenza Vaccines. NEJM Evidence, 2(2).doi.org/10.1056/evidoa2200206
Friedman DJ, Al-Khatib SM, Dalgaard F, et al. Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials. Circulation. 2023;147(10):812-23. doi: 10.1161/CIRCULATIONAHA.122.062124.
Diederichsen SZ, Xing LY, Frodi DM, et al. Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial. JAMA Cardiol. 2023;8(4):326-34. doi: 10.1001/jamacardio. 2022. 5526.
Edelstein GE, Boucau J, Uddin R, et al. SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy. medRxiv. 2023:2023.06.23.23288598. doi: 10.1101/2023.06.23.23288598.
Epling BP, Rocco JM, Boswell KL, et al. Clinical, virologic, and immunologic evaluation of symptomatic coronavirus disease 2019 rebound following nirmatrelvir/ritonavir treatment. Clin Infect Dis. 2023; 76:573-81. doi: 10.1093/cid/ciac663.
Ioannou GN, Berry K, Rajeevan N et al.. Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation. Ann Intern Med. 2023;176(11):1486-97. doi: 10.7326/M23-1394.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Domenico Cucinotta
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
